Aardvark Therapeutics, Inc. (AARD) › Operating Cash FlowAardvark Therapeutics, Inc. (AARD) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2024: -$18.09M2025: -$54.17M-$54.17M2024Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$54.17M-199.5%2024-$18.09M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share